Abstract | PURPOSE:
Perifosine has shown antitumor activity via inhibition of Akt phosphorylation in many advanced solid tumors. This study investigated the efficacy of perifosine alone and in combination with sorafenib in a transgenic mouse model of HCC. METHODS: The mouse model of HCC was generated by hydrodynamic injection of transposons encoding HrasG12V and short-hairpin RNA downregulating p53. The transgenic mice were treated with perifosine alone and in combination with sorafenib to evaluate efficacy of drugs on tumor growth and survival. RESULTS: CONCLUSIONS: The preclinical effect that current study showed represents a strong rationale for clinical trials using perifosine alone and in combination with sorafenib in the treatment of HCC patients.
|
Authors | Mi Na Kim, Simon Weonsang Ro, Do Young Kim, Da Young Kim, Kyung-Ju Cho, Jeon Han Park, Ho Yeong Lim, Kwang-Hyub Han |
Journal | Cancer chemotherapy and pharmacology
(Cancer Chemother Pharmacol)
Vol. 76
Issue 2
Pg. 257-67
(Aug 2015)
ISSN: 1432-0843 [Electronic] Germany |
PMID | 26037205
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- DNA Transposable Elements
- Phenylurea Compounds
- RNA, Small Interfering
- Tumor Suppressor Protein p53
- Phosphorylcholine
- Niacinamide
- perifosine
- Sorafenib
- Poly(ADP-ribose) Polymerases
- Caspase 3
- Caspase 9
- HRAS protein, human
- Proto-Oncogene Proteins p21(ras)
|
Topics |
- Animals
- Antineoplastic Agents
(therapeutic use)
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Apoptosis
(drug effects)
- Carcinoma, Hepatocellular
(blood supply, drug therapy, pathology)
- Caspase 3
(metabolism)
- Caspase 9
(metabolism)
- Cell Proliferation
(drug effects)
- DNA Transposable Elements
- Drug Synergism
- Liver Neoplasms, Experimental
(blood supply, drug therapy, pathology)
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
- Neovascularization, Pathologic
(drug therapy)
- Niacinamide
(analogs & derivatives, therapeutic use)
- Phenylurea Compounds
(therapeutic use)
- Phosphorylcholine
(analogs & derivatives, therapeutic use)
- Poly(ADP-ribose) Polymerases
(metabolism)
- Proto-Oncogene Proteins p21(ras)
(genetics)
- RNA, Small Interfering
(genetics)
- Sorafenib
- Tumor Suppressor Protein p53
(genetics)
|